About
This Bill will address economic barriers to participation in clinical trials by:
- Exempting free digital health technology that enables trial participation from the Anti-Kickback statute when doing so will facilitate clinical trial participation by underrepresented populations;
- Allowing patient cost-sharing by a drug or device manufacturer in a clinical trial when specific criteria are met;
- Excluding remuneration for participation in clinical trials from taxable income.
See Full Bill